Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Transfusion ; 43(4): 536-40, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12662288

RESUMEN

BACKGROUND: Currently, individuals donating whole blood and cellular components are not screened for hepatitis A (HA). However, transfusion-transmitted HA can occur, albeit very rarely. Although infection is typically mild and self-limited, it may be catastrophic in a small percentage of cases. Two cases of HA transmission from a single donation to two patients with subsequent variable morbidity are reported. CASE REPORTS: A 50-year-old, asymptomatic, volunteer blood donor made a whole-blood donation. He was found to have HA 18 days later. When notified, the donor center initiated a recall of the components produced from the donated unit. However, the RBCs and FFP had already been transfused. Subsequently, both recipients developed HA as documented by IgM anti-HA serology. The RBC recipient was a 49-year-old woman, transfused after a hysterectomy, who was found to have HA at the time of unit recall (20 days after transfusion). Her condition required the use of medical disability leave. The FFP was infused to a 52-year-old female cardiac surgical patient. Her course was marked by multiple complications, including postoperative development of mild hepatic dysfunction. After testing negative for HA, hepatitis B, and hepatitis C (24 days after transfusion), she suffered a second bout of more severe hepatic dysfunction and was documented to have HA at Day 55 after transfusion. Evaluation of both recipients' close contacts revealed no evidence for exposure to HA by any route other than transfusion. CONCLUSION: HA can be transmitted by transfusion of units obtained from asymptomatic, infectious donors. Two patients contracted HA from components obtained from a single whole-blood donation. The RBC recipient had a typical self-limited course of HA. The FFP recipient developed HA of relatively delayed onset. Both recovered from HA.


Asunto(s)
Eliminación de Componentes Sanguíneos , Donantes de Sangre , Transfusión de Eritrocitos/efectos adversos , Hepatitis A/transmisión , Leucocitos , Plasma , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Estenosis de la Válvula Aórtica/cirugía , Aspartato Aminotransferasas/sangre , Bilirrubina/sangre , Resultado Fatal , Femenino , Prótesis Valvulares Cardíacas , Hepatitis A/diagnóstico , Anticuerpos de Hepatitis A/sangre , Humanos , Histerectomía , Masculino , Persona de Mediana Edad , Estenosis de la Válvula Mitral/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...